JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Houle, S.
Right arrow Articles by Marceau, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Houle, S.
Right arrow Articles by Marceau, F.

Vol. 294, Issue 1, 45-51, July 2000

Effect of Allelic Polymorphism of the B1 and B2 Receptor Genes on the Contractile Responses of the Human Umbilical Vein to Kinins1

Steeve Houle, Michelle Landry2, Ritchie Audet3, Johanne Bouthillier, Dimcho R. Bachvarov4 and François Marceau

Centre Hospitalier Universitaire de Québec, Centre de recherche du Pavillon l'Hôtel-Dieu de Québec, Quebec, Canada

The human genes corresponding to the two receptor (R) subtypes for bradykinin (BK)-related peptides, the B1R and B2R, are known to be polymorphic. The human isolated umbilical vein responds by contractions to stimulation by kinins via constitutive B2Rs and inducible B1Rs. Vascular rings from 100 different umbilical cords were submitted to a standardized protocol where Emax values were obtained at 2 and 6 h of incubation, and EC50 values were estimated at 6 h for the B1R agonist Sar-[D-Phe8]des-Arg9-BK; Emax and EC50 values were also obtained for the B2R agonist BK at 4 h. The genotype of each tissue donor was determined for two polymorphic sites in the B1R gene and three such sites in the B2R gene. The (-/-) genotype of a frequent insertion/deletion polymorphism of the B2R exon 1 was associated with increased contractile efficiency of the B1R agonist, Sar-[D-Phe8]des-Arg9-BK, but had no effect on BK-induced contractility. A B2R exon 2 polymorphism (C181 right-arrow T) selectively influenced the potency of BK (EC50 higher when the T allele was present). The other polymorphisms studied were not found to affect kinin-induced contractility. Although most of the frequent polymorphic alleles of the kinin receptor genes are functionally neutral or determine functional alterations that are not detectable using the method used here, two B2R polymorphic sites (exon 1, exon 2) modestly influence function. As the exon 1 B2R polymorphism predicts the response of the B1R agonist, it may be in linkage disequilibrium with an unknown, functionally important polymorphism of the neighboring B1R gene.


1 This work was supported by Medical Research Council of Canada Grant MT-14077.

2 Recipient of a studentship from the Medical Research Council of Canada.

3 Present address: DiagnoCure Inc., 2050 René-Lévesque Ouest Blvd., Sainte-Foy (Québec), Canada G1V 2K8.

4 Recipient of the Ernest J. B. Tomlinson Scholarship Award from the Kidney Foundation of Canada and of a Fonds de la Recherche en Santé du Québec Scholarship, successively.


0022-3565/00/2941-0045$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. S. Dhamrait, J. R. Payne, P. Li, A. Jones, I. S. Toor, J. A. Cooper, E. Hawe, J. M. Palmen, P. T.E. Wootton, G. J. Miller, et al.
Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension
Eur. Heart J., September 2, 2003; 24(18): 1672 - 1680.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Maestri, A. F. Milia, M. B. Salis, G. Graiani, C. Lagrasta, M. Monica, D. Corradi, C. Emanueli, and P. Madeddu
Cardiac Hypertrophy and Microvascular Deficit in Kinin B2 Receptor Knockout Mice
Hypertension, May 1, 2003; 41(5): 1151 - 1155.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.